Biopharma SHAKTI: Stocks in focus after 2026 budget

The Budget announcement included an expenditure of ₹10,000 crore to develop biopharmaceutical manufacturing in India. Over the next five years, the biopharmaceutical focus will be developed in educational institutions through NIPERS (National Institute of Pharmaceutical Education and Research) and even its regulatory arm – CDSCO (Central Drugs Standard Control Organization). The plan also includes the […]